SENATE FLOOR VERSION - SB1219 SFLR Page 1
(Bold face denotes Committee Amendme nts) 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
SENATE FLOOR VERSION
February 17, 2022
AS AMENDED
SENATE BILL NO. 1219 By: Bullard
[ medical marijuana - requirements for edible medical
marijuana products - effective date ]
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTION 1. AMENDATORY 63 O.S. 2021, Section 427.18, is
amended to read as follows:
Section 427.18. A. An Oklahoma medical marijuana business
shall not sell, transfe r, or otherwise distribute medical marijuana
or medical marijuana product that has not been packaged and labeled
in accordance with this sec tion and rules promulgated by the State
Commissioner of Health.
B. A medical marijuana dispensa ry shall return medic al
marijuana and medical marijuana product that does not meet p ackaging
or labeling requirements in this sectio n or rules promulgated
pursuant thereto to the entity who transferred it to the dispensary .
The medical marijuana dispensar y shall document to w hom the item was
returned, what was returned and the date of th e return or dispose of
any usable marijuana that does not meet these require ments in
SENATE FLOOR VERSION - SB1219 SFLR Page 2
(Bold face denotes Committee Amendme nts) 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
accordance with the Oklahoma Medical Marijuana and Patient
Protection Act.
C. 1. Medical marijuana packagi ng shall be packaged to
minimize its appeal to children and sha ll not depict images other
than the business nam e logo of the medical mariju ana producer and
image of the product.
2. A medical marijuana business shall not place any co ntent on
a container in a manner that reasonably appears to target
individuals under the age of twenty-one (21) including, but not
limited to, cartoon characters or similar images.
3. Labels on a container shall not include any false or
misleading statements.
4. No container shall be intentionally or knowingly labeled so
as to cause a reasonable patient confusion as to whether the medi cal
marijuana, medical marij uana concentrate, or medical marijuana
product is a trademarked product or labeled in a manne r that
violates any federal trademark law or regulation.
5. The label on the container shall not make any claims
regarding health or p hysical benefits to the patie nt.
6. a. All medical marijuana, medical marijuana concentrate
and medical marijuana product s shall be in a child-
resistant container at the point of transfer to the
patient or caregiver. For all edible medical
SENATE FLOOR VERSION - SB1219 SFLR Page 3
(Bold face denotes Committee Amendme nts) 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
marijuana products, the child-resistant container
shall be clear.
b. Edible medical marijuana products in solid or
semisolid form shall be in the shape of a marijuana
leaf. This subparagraph shall not apply to edible
medical marijuana products in liquid form.
D. The State Department of Health shall develop minimum
standards for packaging and labeling of medical marijuana and
medical marijuana products . Such standards shall include, but not
be limited to, the required cont ents of labels to be affixed to all
medical marijuana and medical marijuana products prior to transfer
to a licensed patient or caregiver, which shall in clude, at a
minimum:
1. THC and other cannabinoid potency, and te rpenoid potency;
2. A statement indicating that the product has been tested for
contaminants;
3. One or more product warnings to be determined by the
Department; and
4. Any other information the Department deems necessary.
SECTION 2. This act shall become effective Novembe r 1, 2022.
COMMITTEE REPORT BY: COMMITTEE ON BUSINESS, COMMERCE AND TOURISM
February 17, 2022 - DO PASS AS AMENDED